mavacamten 5 MG Oral Capsule
- RxCUI
- 2600888
- RxNorm name
- mavacamten 5 MG Oral Capsule
- Display name
- mavacamten 5 MG Oral Capsule
- Full name
- mavacamten 5 MG Oral Capsule
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CAMZYOS | MAVACAMTEN | Myokardia, Inc. | 669c936b-3ee6-4e36-8a22-79dd11b1255b | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | 2600888 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 669c936b-3ee6-4e36-8a22-79dd11b1255b | mavacamten 5 MG Oral Capsule [PSN] · mavacamten 5 MG Oral Capsule [SCD] | 2 | 8 | These highlights do not include all the information needed to use CAMZYOS safely and effectively. See full prescribing information for CAMZYOS. CAMZYOS ® (mavacamten) capsules for oral use Initial U.S. Approval: 2022 | 20250417 |